Onchocerciasis Control: Vision for the Future from a Ghanian perspective

Mark Taylor; Kwablah Awadzi; María Gloria Basá̃ez; Nana Biritwum; Daniel Boakye; Boakye Boatin; Moses Bockarie; Thomas S. Churcher; Alex Debrah; Geoffrey Edwards; Achim Hoerauf; Sabine Mand; Graham Matthews; Mike Osei-Atweneboana; Roger K. Prichard; Samuel Wanji; Ohene Adjei

doi:10.1186/1756-3305-2-7

Onchocerciasis Control: Vision for the Future from a Ghanian perspective

Mark Taylor, Kwablah Awadzi, María Gloria Basá̃ez, Nana Biritwum, Daniel Boakye, Boakye Boatin, Moses Bockarie, Thomas S. Churcher, Alex Debrah, Geoffrey Edwards, Achim Hoerauf, Sabine Mand, Graham Matthews, Mike Osei-Atweneboana, Roger K. Prichard, Samuel Wanji, Ohene Adjei

Tropical Disease Biology

Research output: Contribution to journal › Article › peer-review

53 Citations (Scopus)

Abstract

Since 1987 onchocerciasis control has relied on the donation of ivermectin (Mectizan (R), Merck & Co., Inc.) through the Mectizan Donation Programme. Recently, concern has been raised over the appearance of suboptimal responses to ivermectin in Ghana - highlighting the potential threat of the development of resistance to ivermectin. This report summarises a meeting held in Ghana to set the research agenda for future onchocerciasis control. The aim of this workshop was to define the research priorities for alternative drug and treatment regimes and control strategies to treat populations with existing evidence of suboptimal responsiveness and define research priorities for future control strategies in the event of the development of widespread ivermectin resistance.

Original language	English
Article number	7
Pages (from-to)	e7
Journal	Parasites and Vectors
Volume	2
Issue number	1
DOIs	https://doi.org/10.1186/1756-3305-2-7
Publication status	Published - 21 Jan 2009

Access to Document

10.1186/1756-3305-2-7Licence: CC BY

Para Vect 2 7Final published version, 219 KBLicence: CC BY

Cite this

Taylor, M., Awadzi, K., Basá̃ez, M. G., Biritwum, N., Boakye, D., Boatin, B., Bockarie, M., Churcher, T. S., Debrah, A., Edwards, G., Hoerauf, A., Mand, S., Matthews, G., Osei-Atweneboana, M., Prichard, R. K., Wanji, S., & Adjei, O. (2009). Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Parasites and Vectors, 2(1), e7. Article 7. https://doi.org/10.1186/1756-3305-2-7

@article{668de4afd937410eb18876928c0508f9,

title = "Onchocerciasis Control: Vision for the Future from a Ghanian perspective",

abstract = "Since 1987 onchocerciasis control has relied on the donation of ivermectin (Mectizan (R), Merck \& Co., Inc.) through the Mectizan Donation Programme. Recently, concern has been raised over the appearance of suboptimal responses to ivermectin in Ghana - highlighting the potential threat of the development of resistance to ivermectin. This report summarises a meeting held in Ghana to set the research agenda for future onchocerciasis control. The aim of this workshop was to define the research priorities for alternative drug and treatment regimes and control strategies to treat populations with existing evidence of suboptimal responsiveness and define research priorities for future control strategies in the event of the development of widespread ivermectin resistance.",

author = "Mark Taylor and Kwablah Awadzi and Bas{\'a}̃ez, \{Mar{\'i}a Gloria\} and Nana Biritwum and Daniel Boakye and Boakye Boatin and Moses Bockarie and Churcher, \{Thomas S.\} and Alex Debrah and Geoffrey Edwards and Achim Hoerauf and Sabine Mand and Graham Matthews and Mike Osei-Atweneboana and Prichard, \{Roger K.\} and Samuel Wanji and Ohene Adjei",

year = "2009",

month = jan,

day = "21",

doi = "10.1186/1756-3305-2-7",

language = "English",

volume = "2",

pages = "e7",

journal = "Parasites and Vectors",

issn = "1756-3305",

publisher = "BioMed Central Ltd",

number = "1",

}

Taylor, M, Awadzi, K, Basá̃ez, MG, Biritwum, N, Boakye, D, Boatin, B, Bockarie, M, Churcher, TS, Debrah, A, Edwards, G, Hoerauf, A, Mand, S, Matthews, G, Osei-Atweneboana, M, Prichard, RK, Wanji, S & Adjei, O 2009, 'Onchocerciasis Control: Vision for the Future from a Ghanian perspective', Parasites and Vectors, vol. 2, no. 1, 7, pp. e7. https://doi.org/10.1186/1756-3305-2-7

TY - JOUR

T1 - Onchocerciasis Control: Vision for the Future from a Ghanian perspective

AU - Taylor, Mark

AU - Awadzi, Kwablah

AU - Basá̃ez, María Gloria

AU - Biritwum, Nana

AU - Boakye, Daniel

AU - Boatin, Boakye

AU - Bockarie, Moses

AU - Churcher, Thomas S.

AU - Debrah, Alex

AU - Edwards, Geoffrey

AU - Hoerauf, Achim

AU - Mand, Sabine

AU - Matthews, Graham

AU - Osei-Atweneboana, Mike

AU - Prichard, Roger K.

AU - Wanji, Samuel

AU - Adjei, Ohene

PY - 2009/1/21

Y1 - 2009/1/21

N2 - Since 1987 onchocerciasis control has relied on the donation of ivermectin (Mectizan (R), Merck & Co., Inc.) through the Mectizan Donation Programme. Recently, concern has been raised over the appearance of suboptimal responses to ivermectin in Ghana - highlighting the potential threat of the development of resistance to ivermectin. This report summarises a meeting held in Ghana to set the research agenda for future onchocerciasis control. The aim of this workshop was to define the research priorities for alternative drug and treatment regimes and control strategies to treat populations with existing evidence of suboptimal responsiveness and define research priorities for future control strategies in the event of the development of widespread ivermectin resistance.

AB - Since 1987 onchocerciasis control has relied on the donation of ivermectin (Mectizan (R), Merck & Co., Inc.) through the Mectizan Donation Programme. Recently, concern has been raised over the appearance of suboptimal responses to ivermectin in Ghana - highlighting the potential threat of the development of resistance to ivermectin. This report summarises a meeting held in Ghana to set the research agenda for future onchocerciasis control. The aim of this workshop was to define the research priorities for alternative drug and treatment regimes and control strategies to treat populations with existing evidence of suboptimal responsiveness and define research priorities for future control strategies in the event of the development of widespread ivermectin resistance.

U2 - 10.1186/1756-3305-2-7

DO - 10.1186/1756-3305-2-7

M3 - Article

SN - 1756-3305

VL - 2

SP - e7

JO - Parasites and Vectors

JF - Parasites and Vectors

IS - 1

M1 - 7

ER -

Onchocerciasis Control: Vision for the Future from a Ghanian perspective

Abstract

Access to Document

Fingerprint

Cite this